ImmuneWatch

Active

Private limited companyfounded 2021active for 5 yearsLange Gasthuisstraat 29-31, 2000 Antwerpen, BelgiumKBO/BCE: BE 0774.472.942

Summary

ImmuneWatch has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€30,203) and a net result of €8,523. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 10% of 605 sector peers (NACE 72, financial year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).

Risk analysisFollow Report Compare

ImmuneWatchActiveChecked score 56/100

Risk analysis Report Compare

History

On 23 September 2021, ImmuneWatch was incorporated as a private limited company.¹ Total assets went from €195,906 in 2022 to €173,740 in 2025 and headcount from 1 to 1 full-time equivalents.²

Acts, filings and financial milestones

All 5Financial 1Filings 4

Next filing, financial year 2026, expected by 31-07-2027

2026

20-07

NBB filing Annual accounts filed

financial year 2025 · micro format

2025

31-12

Financial Back to profitnet €8,523

Net result €8,523 after 3 loss-making years.

11-07

NBB filing Annual accounts filed

financial year 2024 · micro format

2024

18-06

NBB filing Annual accounts filed

financial year 2023 · micro format

2023

21-06

NBB filing Annual accounts filed

financial year 2022 · micro format

Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.

0 of 5 deeds read

About the unread acts

We know of 5 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.